Internal Medicine NewsNovel drug slows progression of diabetic kidney diseaseOctober 29, 2020DiabetesNephrologyCardiologyMixed Topics
Internal Medicine NewsExperts tout immediate quadruple therapy for HFrEF patientsOctober 20, 2020DiabetesCardiology
Internal Medicine NewsCOVID-19 antibody response not reduced with diabetesOctober 20, 2020DiabetesCOVID-19 UpdatesInfectious DiseasesEndocrinology
Internal Medicine NewsSubstance in tears could be used for diabetes monitoringOctober 16, 2020Diabetes
Entresto halves renal events in preserved EF heart failure patientsOctober 15, 2020DiabetesCardiologyEndocrinology
Internal Medicine NewsT2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesPreventive CareCardiologyEndocrinology
Internal Medicine NewsEmpagliflozin cut PA pressures in heart failure patientsOctober 12, 2020CardiologyPulmonologyDiabetesEndocrinology
Internal Medicine NewsEMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020DiabetesCardiologyEndocrinology
Internal Medicine NewsPPIs associated with diabetes risk, but questions remainOctober 6, 2020DiabetesHeartburn/Acid RefluxGastroenterology
Internal Medicine NewsTime to screen for liver disease in type 2 diabetes?October 5, 2020DiabetesGastroenterology
Internal Medicine NewsDapagliflozin’s CKD performance sends heart failure messagesOctober 5, 2020DiabetesEndocrinologyCardiologyNephrology
Internal Medicine NewsBritish protocol allows insulin-treated pilots to fly safelyOctober 1, 2020Diabetes
Internal Medicine NewsAHA scientific statement highlights cardiorenal benefit of new diabetes drugsOctober 1, 2020DiabetesCardiologyEndocrinology
Internal Medicine NewsGeriatric patients: My three rules for themOctober 1, 2020Preventive CareMixed TopicsGeriatricsNeurologyCardiologyDiabetes
